Inside the Epstein files ...
Very strong Q4 2025 at +5.9% Confident in delivering a 7th year of outperformance in 2026 February 3, 2026 +5.9% Q4 organic growth, leading to +5.6% in 2025Solid FY performance across all regions: U.S ...
SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnological company focused on treating inflammation through resolution therapy, today announced that it has initia ...
Active host-pathogen interactions take place during infection of human immunodeficiency virus type 1 (HIV-1). Outcomes of these interactions determine the efficiency of viral infection and subsequent ...
Canada's Carney wins admiration globally but struggles to lower food costs at home Canadian Prime Minister Mark Carney has earned global admiration for openly declaring the end of a global order based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results